NIA commentary: translational issues in Alzheimer's disease drug development
Neuropsychopharmacology
.
2012 Jan;37(1):284-6.
doi: 10.1038/npp.2011.116.
Authors
Neil S Buckholtz
1
,
Laurie M Ryan
,
Suzana Petanceska
,
Lorenzo M Refolo
Affiliation
1
Division of Neuroscience, National Institute on Aging, Bethesda, MD 20892, USA. buckholn@nia.nih.gov
PMID:
22157857
PMCID:
PMC3238059
DOI:
10.1038/npp.2011.116
No abstract available
MeSH terms
Aged
Alzheimer Disease / drug therapy*
Animals
Drug Design*
Humans
National Institute on Aging (U.S.) / trends*
Neuropharmacology / trends*
Translational Research, Biomedical / trends*
United States